Definitive Healthcare - Class A opened lower at $1.27, compared with its previous close of $1.28. In the last trading session, the stock traded between $1.25 and $1.32. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Definitive Healthcare - Class A is now worth
$ 2.92
Resulting in a loss of
$ 97.08 (97.08%)
Note: Past profits do not guarantee future returns.
Rating from 5 Analysts
Today's Change
$-0.04 (-2.73%)
Day High
$1.32
Day Low
$1.25
Day Open
$1.27
Prev Close
$1.28
Volume
3,43,895
1W Return
1.63%
1M Return
27.82%
3M Return
93.02%
6M Return
25.96%
1Y Return
-56.62%
Market Cap ($ Mn)
133
PE Ratio
-
PB Ratio
0.59
PEG Ratio
-
ROE
-60.88%
ROCE
-30.31%
EPS (TTM)
$-0.04
1 Week
1.63%
1 Month
27.82%
3 Months
93.02%
6 Months
25.96%
9 Months
-26.33%
Definitive Healthcare appoints Marani and Attipalli to lead AI strategy
Definitive Healthcare appointed Rebecca Marani as Chief Product Officer and Srinivas Attipalli as SVP, Head of AI and Data. The leadership expansion supports the upcoming launch of a new AI-powered intelligence platform. The new platform aims to reduce data research time from months to minutes for healthcare decisions. An early adopter program for the AI platform is underway, with initial findings to be shared at HLTH.
8 days agoAdvent proposes $1.02 per share to take Definitive Healthcare private
Advent International proposes $1.02 per share to take Definitive Healthcare private. Non-binding offer targets all outstanding shares and OpCo units not owned by insiders. Special committee of independent directors will evaluate the proposal with advisors. Rothschild & Co advises the committee; Evercore advises the company.
2mo agoDefinitive Healthcare appoints Clay Ritchey as next CEO
Clay Ritchey appointed CEO of Definitive Healthcare effective September 8, 2026. Kevin Coop departs as CEO and board member effective August 31, 2026. Ritchey brings over 25 years of experience in healthcare data and technology. Former CEO of Verato, Evariant, Equinox Healthcare, and CMO of Imprivata. Focuses on accelerating growth via new AI-powered platform launch.
2mo agoDefinitive Healthcare revenue falls 9% in Q2, cash flow holds
Definitive Healthcare's Q2 2026 results show a 9% revenue decline to $55.2 million, yet the company maintained strong cash flow generation of $11.6 million. Adjusted net income fell to $7.5 million from $9.7 million last year. The firm highlighted strategic wins, including a major win-back deal and the launch of its Turbo AI platform, while guiding for full-year revenue between $220.0 million and $222.0 million.
3mo agoDefinitive Healthcare Raises FY26 Adj EPS Guidance to $0.18-$0.20
Definitive Healthcare raises FY2026 adjusted EPS guidance to $0.18-$0.20, beating the $0.18 estimate. Simultaneously, it narrows sales guidance to $220.000M-$222.000M, missing the $223.449M estimate, signaling margin focus over revenue growth.
3mo agoDefinitive Healthcare Q3 Results: Sales and EPS miss estimates
Definitive Healthcare reports Q3 guidance with Adj EPS of $0.04-$0.05 and sales of $54-$55 million. While EPS meets or beats the $0.04 estimate, sales miss the $55.542 million consensus, highlighting top-line pressure.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $506.04 | +0.32% | $1,05,708.21M | 14.01 | |
| $304.77 | -0.26% | $49,345.01M | 45.36 | |
| $292.97 | +0.93% | $23,316.90M | 10.31 | |
| $72.62 | +0.18% | $14,450.29M | 52.31 | |
| $79.43 | -1.38% | $14,087.55M | - | |
| $142.24 | -0.19% | $13,957.16M | 20.21 | |
| $22.22 | -2.29% | $11,935.03M | 11.93 | |
| $183.50 | +2.35% | $11,542.15M | 15.26 | |
| $186.19 | +0.59% | $10,862.51M | 27.11 | |
| $196.77 | +0.70% | $10,170.65M | 7.00 | |
| $103.03 | -0.49% | $8,522.13M | 34.79 | |
| $50.06 | +1.96% | $7,945.72M | 25.00 |
An investment of $100 made 5 years ago in Definitive Healthcare - Class A is now worth
$ 2.92
Resulting in a loss of
$ 97.08 (97.08%)
Note: Past profits do not guarantee future returns.
